Breaking News Instant updates and real-time market news.

AFL

Aflac

, GME

GameStop

09:40
01/12/18
01/12
09:40
01/12/18
09:40

Unusually active option classes on open January 12th

Unusual total active option classes on open include: AFLAC (AFL), GameStop (GME), Transocean (RIG), Kinder Morgan (KMI), Wells Fargo (WFC), Goldman Sachs (GS), Alphabet Class A (GOOGL), Teva (TEVA), General Motors (GM), and Macy's (M).

AFL

Aflac

GME

GameStop

RIG

Transocean

KMI

Kinder Morgan

WFC

Wells Fargo

GS

Goldman Sachs

GOOGL

Alphabet Class A

$1,112.05

1.91 (0.17%)

TEVA

Teva

GM

General Motors

M

Macy's

  • 12

    Jan

  • 16

    Jan

  • 17

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 27

    Feb

  • 18

    Mar

AFL Aflac

09/26/17
SBSH
09/26/17
DOWNGRADE
Target $79
SBSH
Sell
Aflac downgraded to Sell from Neutral at Citi
Citi analyst Suneet Kamath downgraded Aflac to Sell and cut his price target for the shares to $77 from $82. The company is at an inflection point as Aflac Japan is too large to show meaningful growth and Aflac U.S. is "too small to move the growth needle," Kamath tells investors in a research note titled "Growth is Hard to Find, Other than in AFL's Valuation Multiples." The analyst estimates the annual earnings growth going forward at 1% and 5%, respectively, which he says is well below peer levels and "at odds" with the stock's valuation.
09/26/17
09/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) and PNC Financial (PNC) were downgraded to Hold from Buy at Deutsche Bank. 2. Aflac (AFL) downgraded to Sell from Neutral at Citi with analyst Suneet Kamath saying the company is at an inflection point as Aflac Japan is too large to show meaningful growth and Aflac U.S. is "too small to move the growth needle." 3. Cardtronics (CATM) downgraded to Market Perform from Outperform at William Blair with analyst Robert Napoli citing the changes in the Australian market. 4. Cheesecake Factory (CAKE), Shake Shack (SHAK), and Habit Restaurants (HABT) were downgraded to Neutral from Outperform at Wedbush. 5. Genocea (GNCA) downgraded to Hold from Buy at Stifel with analyst Stephen Willey saying his visibility and confidence "remains admittedly low" after the company shelved GEN-003 and said it will shift focus on immuno-oncology and the development of neoantigen cancer vaccines. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/17
GSCO
10/18/17
INITIATION
Target $88
GSCO
Neutral
Aflac initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Alex Scott started Aflac with a Neutral rating and $88 price target while initiating coverage of the life insurance industry with a Neutral coverage view.
01/09/18
WELS
01/09/18
NO CHANGE
Target $90
WELS
Market Perform
Aflac price target raised to $90 from $84 at Wells Fargo
Wells Fargo analyst Sean Dargan raised his price target for Aflac to $90 from $84 after adjusting his Q4 2017, 2018 and 2019 EPS estimates. The analyst reiterates a Market Perform rating on the shares.
GME GameStop

01/12/18
LOOP
01/12/18
NO CHANGE
Target $26
LOOP
Buy
GameStop price target lowered to $26 from $28 at Loop Capital
Loop Capital analyst Anthony Chukumba said he saw several encouraging signs in GameStop's report of better than expected 2017 holiday sales. He keeps a Buy rating on the stock, but trimmed his price target on GameStop shares to $26 from $28, noting that the company also said it now sees FY17 EPS near the middle of its prior guidance range.
01/10/18
BARD
01/10/18
NO CHANGE
Target $23
BARD
Outperform
GameStop holiday results expected to be inline, says Baird
Baird analyst Colin Sebastian said he expects GameStop to report inline holiday sales, seeing strength in top-selling software and hardware products that should offset a few weak performers. He noted his channel checks do not include the sale of collectibles, which is becoming a larger part of GameStop's business. Sebastian reiterated his Outperform rating and $23 price target but said he would be more constructive on GameStop shares below $20.
12/07/17
BARD
12/07/17
NO CHANGE
BARD
Data so far suggesting healthy holiday game sales, says Baird
Baird analyst Colin Sebastian noted that French game maker Ubisoft (UBSFY) raised its revenue and margin guidance for the December quarter, which he views as a slight positive for video game industry sales momentum this holiday season. Data also point to solid sales for both Sony's (SNE) PS4 and Nintendo's (NTDOY) Switch, which are a driver of software as well as a key catalyst for Gamestop (GME), Sebastian added. Other publicly traded companies in the video game space include Activision Blizzard (ATVI), Electronic Arts (EA), Take-Two (TTWO) and Microsoft (MSFT).
11/30/17
LOOP
11/30/17
NO CHANGE
Target $28
LOOP
Buy
GameStop rollout of Pokemon Centers makes "infinite sense", says Loop Capital
Loop Capital analyst Anthony Chukumba says GameStop decision to roll out Pokemon Centers at its GameStop and ThinkGeek stores adds to the company's larger collectibles initiative and "makes infinite sense" due to the popularity of the franchise. Chukumba keeps his Buy rating and $28 price target on GameStop, saying collectibles are a natural product extension for its business.
RIG Transocean

01/04/18
JEFF
01/04/18
UPGRADE
Target $13
JEFF
Buy
Transocean upgraded to Buy from Hold at Jefferies
Jefferies analyst Brad Handler upgraded Transocean to Buy with an increased price target of $13. The analyst believes the company has earnings stability relative to peers and finds the valuation "cheap" at current levels.
10/19/17
HSBC
10/19/17
INITIATION
Target $11.5
HSBC
Hold
Transocean initiated with a Hold at HSBC
HSBC analyst David Phillips started Transocean with a Hold rating and $11.50 price target. The analyst sees a lack of potential upside given the company's "weaker medium-term liquidity profile."
10/12/17
10/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delta Air Lines (DAL) upgraded to Outperform from In-Line at Imperial Capital with analyst Michael Derchin saying the company is likely to grow unit revenues in fiscal year 2018 due to pricing power in its key domestic hubs and improving international results. 2. Transocean (RIG) upgraded to Buy from Neutral at Citi with analyst Scott Gruber saying if an upturn is forthcoming, Transocean should outperform given a "diminution" of concern toward its balance sheet and more new contract catalysts. 3. Canadian Pacific (CP) upgraded to Overweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he sees a shift to stronger volume growth as the company laps contract losses and records some new contract wins. 4. Infinity upgraded to Outperform from Market Perform at Wells Fargo with analyst Jim Birchenough saying the IPI-549 monotherapy data have a "reasonable likelihood" of proof-of-concept response rate, and with likely validation of tumor macrophage targeting in immunooncology and a unique mechanism of action, upside potential is not reflected in the current stock price. 5. Kroger (KR) upgraded to Equal Weight from Underweight at Stephens with analyst Ben Bienvenu saying he believes the pursuit of strategic alternatives for the convenience store business has potential to unlock value and that the risk/reward is more balanced following the stock's recent pullback. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/17
SBSH
10/12/17
DOWNGRADE
Target $12
SBSH
Sell
Diamond Offshore downgraded to Sell from Neutral at Citi
Citi analyst Scott Gruber downgraded Diamond Offshore (DO) to Sell and keeps a $12 price target for the shares. The analyst initiated a pair trade by also upgrading Transocean (RIG) this morning to Buy. Gruber, while still finding it premature to be bullish on offshore driller fundamentals, says that if an upturn is forthcoming, Transocean should outperform given a "diminution" of concern toward its balance sheet and more new contract catalysts. If the downturn persists, then Diamond Offshore is likely to underperform as its backlog is consumed, Gruber tells investors in a research note previewing Q3 earnings for the sector. He believes Diamond Offshore is "simply overvalued" and that Transocean is the "industry leader who's ready to lead."
KMI Kinder Morgan

01/11/18
01/11/18
UPGRADE

Overweight
TransCanada upgraded on defensive positioning, valuation at Morgan Stanley
As previously reported, Morgan Stanley analyst Tom Abrams upgraded TransCanada (TRP) to Overweight from Equal Weight as he believes Midstream valuations are now more defensibly attractive and he prefers the companies in the space with some defensive characteristics. He also has Overweight ratings on Williams (WMB), Williams Partners (WPZ), Enterprise Products (EPD) and Kinder Morgan (KMI).
01/04/18
FBCO
01/04/18
INITIATION
Target $23
FBCO
Outperform
Kinder Morgan initiated with an Outperform at Credit Suisse
Credit Suisse analyst Kristina Kazarlan initiated Kinder Morgan with an Outperform rating and a price target of $23. The analyst says the valuation suggests the MLP may not need a direct catalyst, adding that "a quiet but well-executed 2018" justifies the rating.
01/09/18
BOFA
01/09/18
INITIATION
Target $20
BOFA
Neutral
Kinder Morgan reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Dennis Coleman reinstated coverage on Kinder Morgan with a Neutral and $20 price target.
01/11/18
WELS
01/11/18
DOWNGRADE
Target $21
WELS
Market Perform
Kinder Morgan downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Michael Blum downgraded Kinder Morgan to Market Perform and cut his price target for the shares to $21 from $24. The combination of "still persistently high" leverage and the headline risk associated with the TransMountain pipeline expansion project could weigh on shares, Blum tells investors in a research note.
WFC Wells Fargo

01/10/18
01/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Neutral from Underweight at Atlantic Equities by analyst John Heagerty, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Wells Fargo shares to $64 from $55. The analyst also upgraded Morgan Stanley (MS) to Overweight this morning, citing the same analysis of the potential benefits from tax reform. 2. Deere upgraded to Outperform from Sector Perform at RBC Capital by analyst Seth Weber, who said he is positive on the company's leadership position in North American farm machinery which is stabilizing and exposure to the earth moving equipment category. The analyst is also constructive on Deere's recent Wirten Group acquisition. 3. Target (TGT) upgraded to Positive from Neutral at Susquehanna. 4. State Street (STT) and BNY Mellon (BK) upgraded to Buy from Neutral at Citi, with analyst Keith Horowitz saying he thinks the trust banks are the best way to play the digital transformation to the cloud and finds the current valuation as attractive. 5. RBS (RBS) upgraded to Overweight from Equal Weight at Morgan Stanley. Analyst Alvaro Serrano also downgraded Barclays (BCS) and Lloyds Banking (LYG). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/18
ATLE
01/10/18
UPGRADE
ATLE
Neutral
Wells Fargo upgraded to Neutral from Underweight at Atlantic Equities
01/10/18
ATLE
01/10/18
UPGRADE
Target $64
ATLE
Neutral
Wells Fargo upgraded to Neutral at Atlantic Equities
As previously reported, Atlantic Equities analyst John Heagerty upgraded Wells Fargo (WFC) to Neutral from Underweight, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Wells Fargo shares to $64 from $55. The analyst also upgraded Morgan Stanley (MS) to Overweight this morning, citing the same analysis of the potential benefits from tax reform.
01/10/18
ATLE
01/10/18
UPGRADE
Target $61
ATLE
Overweight
Morgan Stanley upgraded on tax reform benefits at Atlantic Equities
As previously reported, Atlantic Equities analyst John Heagerty upgraded Morgan Stanley (MS) to Overweight from Neutral, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Morgan Stanley shares to $61 from $48. The analyst also upgraded Wells Fargo (WFC) to Neutral from Underweight this morning, citing the same analysis of the potential benefits from tax reform.
GS Goldman Sachs

12/08/17
VERF
12/08/17
UPGRADE
VERF
Hold
Goldman Sachs upgraded to Hold from Sell at Vertical Group
12/08/17
VERF
12/08/17
UPGRADE
Target $249
VERF
Hold
Goldman Sachs upgraded to Hold from Sell at Vertical Group
Vertical Group analyst Richard Bove upgraded Goldman Sachs to Hold and raised his price target for the shares to $249.
12/20/17
WELS
12/20/17
NO CHANGE
Target $295
WELS
Outperform
Goldman Sachs price target raised to $295 from $265 at Wells Fargo
Wells Fargo analyst Mike Mayo raised his price target for Goldman Sachs to $295 from $265 to reflect more potential upside from a portion of higher interest rates, lower taxes, and lower cost of capital due to greater resiliency. The analyst reiterates an Outperform rating on the shares.
12/29/17
VERF
12/29/17
UPGRADE
Target $276.07
VERF
Buy
Goldman Sachs upgraded to Buy from Hold at Vertical Group (pre-open)
Pre-open, Vertical Group's Dick Bove upgraded Goldman Sachs to Buy with a $276.07 price target and raised his 2017 earnings estimate to $19.53 from $18.92 per share excluding the one-time charge, 2018 to $20.77 from $20.64, 2019 to $23.79 from $21.91, and established a 2020 earnings estimate of $24.79.
GOOGL Alphabet Class A
$1,112.05

1.91 (0.17%)

01/12/18
MSCO
01/12/18
NO CHANGE
MSCO
Morgan Stanley most bullish on Amazon in large-cap internet
Morgan Stanley analyst Brian Nowak issued his 2018 outlook for U.S. internet names, saying among the large caps he is bullish on Amazon (AMZN) as he sees growing high margin revenues leading to upward revisions of estimates for the company. He is also positive on Facebook (FB), contending that core Facebook ad unit pricing can rise over 20% in 2018 and Instagram can add about $16B in ad revenue. Nowak also keeps an Overweight rating on Alphabet (GOOG), as he expects innovation to drive beats on revenue and profits. He has a $1,250 price target on Amazon, $215 price target on Facebook and a $1,210 target on Alphabet.
01/11/18
PIPR
01/11/18
NO CHANGE
Target $1300
PIPR
Overweight
Alphabet price target raised to $1,300 from $1,150 at Piper Jaffray
Piper Jaffray analyst Sam Kemp raised his price target on Alphabet (GOOG) to $1,300, saying Google Cloud Platform is gaining mindshare from smaller competitors in the public cloud space amid "ongoing feature improvements, accompanying platform evangelism, and adoption by younger companies". The analyst contends that as a #3 player in the field behind Amazon's (AMZN) AWS and Microsoft's (MSFT) Azure, GCP can still create "meaningful shareholder value" within the accelerating cloud environment. Kemp keeps his Overweight rating on Alphabet.
01/11/18
PIPR
01/11/18
NO CHANGE
PIPR
Overweight
Amazon's AWS still the leading public cloud offering, says Piper Jaffray
Piper Jaffray analyst Michael Olson reported that the firm's 2018 survey of CIOs shows that Amazon's (AMZN) AWS remains the leading public cloud offering in terms of revenue and scale and is tied with Microsoft's (MSFT) Azure for mindshare, which is a change from last year when AWS had lost some mindshare amid "early-2017 hype" regarding the maturation of Azure's offering. 90% of CIOs surveyed intend to increase AWS spending in 2018, which is up from 87% in 2017, Olson added. Azure maintained mindshare and Google Cloud Platform (GOOG) saw a significant step up in mindshare, while smaller cloud providers rapidly lose mindshare, noted Olson.
01/10/18
JPMS
01/10/18
NO CHANGE
Target $1385
JPMS
Overweight
Amazon can be $1 trillion company over time, says JPMorgan
Amazon.com (AMZN) has the potential to be a $1 trillion dollar company over time, as it remains early in the e-commerce and cloud secular shifts, JPMorgan analyst Doug Anmuth tells investors in a research note. The shares closed yesterday up $5.83 to $1,252.70, which represents a market capitalization of around $603 billion. The analyst says Amazon is investing in more major growth opportunities than any other company he covers. Anmuth views Amazon as a top pick for 2018 and upped his price target for the shares to $1,385 from $1,375. He reiterates an Overweight rating on the name. Amazon shares increased 56% in 2017, more than Netflix (NFLX), Facebook (FB) and Alphabet (GOOG, GOOGL), Anmuth points out. He thinks Amazon will outperform again in 2018.
TEVA Teva

01/11/18
GSCO
01/11/18
NO CHANGE
Target $25
GSCO
Buy
Teva price target raised to $25 from $20 at Goldman Sachs
Goldman analyst Jami Rubin raised Buy rated Teva's price target to $25 from $20 following the recent investor presentation and management meetings. The analyst believes investor concerns regarding debt issue/downgrade risk combine with the impact from topline portfolio optimization are overstated. Rubin believes there could actually be upside to Copaxone estimates and further FTF opportunities and has increased confidence in the company's deleveraging path.
01/09/18
BMOC
01/09/18
NO CHANGE
Target $26
BMOC
Outperform
Alder Biopharmaceuticals price target raised to $26 from $22 at BMO Capital
BMO Capital analyst Matthew Luchini raised his price target on Alder Biopharmaceuticals (ALDR) to $26 after the release of PROMISE-2 Phase III data in chronic migraine and announcement of settlement with Teva (TEVA) which allows Alder to operate internationally. Luchini says the Phase III update for PROMISE-2 indicates a "competitive profile with potential advantage in chronic setting" for the eptinezumab drug with superior response rates relative to competition. The analyst is keeping his Outperform rating on Alder Biopharmaceuticals.
01/09/18
01/09/18
UPGRADE
Target $23

Buy
Teva upgraded to Buy at Mizuho
As previously reported, Mizuho analyst Irina Koffler upgraded Teva to Buy from Neutral after updating her model for heavier cost cutting, 2017 asset divestitures and slower generic deterioration. The analyst also raised her price target on the shares to $23 from $16.
01/09/18
MZHO
01/09/18
UPGRADE
MZHO
Buy
Teva upgraded to Buy from Neutral at Mizuho
GM General Motors

12/19/17
RBCM
12/19/17
UPGRADE
Target $52
RBCM
Outperform
General Motors upgraded to Outperform at RBC Capital on downturn resiliency
As reported earlier, RBC analyst Joseph Spak upgraded Generat Motors to Outperform from Sector Perform and nudged his price target to $52 from $51. Spak cites "increased confidence on downturn resiliency" in 2018, noting that while he anticipates a decline in fullsize pickup truck sales, he does not see "GMNA profitability to be down as much as previously forecast". The analyst models FY18 EPS of $6.30, about 9% above consensus view.
12/19/17
12/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Joseph Spak citing "increased confidence on downturn resiliency" in 2018, noting that while he anticipates a decline in fullsize pickup truck sales, he does not see "GMNA profitability to be down as much as previously forecast". 2. Walmart (WMT) upgraded to Buy from Neutral at Citi with analyst Kate McShane saying the stock has "more room to run" in 2018. 3. Ulta Beauty (ULTA) upgraded to Buy from Neutral at Buckingham with the firm saying they recommend adding to positions given "extremely" attractive valuation and better flow through profitability that will deliver 20%+ earnings growth over the next two years or more. 4. Cabot (CBT) upgraded to Buy from Hold at SunTrust with analyst James Sheehan saying the improving global supply/demand fundamentals, along with tighter emissions controls in China, warrant the rating change. 5. Altria Group (MO) upgraded to Buy from Hold at Berenberg with analyst Jonathan Leinster saying he assumes that the company's headline tax rate will decline from historical levels of 35-36% to 21-22% due to the Republicans' proposed U.S. corporate tax changes. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/28/17
MSCO
12/28/17
NO CHANGE
MSCO
January to be busy for Autos and Shared Mobility names, says Morgan Stanley
Morgan Stanley analyst Adam Jonas previewed the January calendar for the Autos and Shared Mobility sector, noting that the Vegas CES takes place in the second week and the Detroit Auto Show occurs in the third week of next month. Judging from last year's shows and press releases in recent weeks, he expects "the vast majority" of prepared presentations will focus on autonomous driving, electric propulsion and new business models as companies seek to encourage recognition and valuation of "Auto 2.0 efforts" in the multiples of their stocks, he tells investors. Automakers covered by the firm include Fiat Chrysler (FCAU), Tesla (TSLA), General Motors (GM), Ferrari (RACE) and Ford (F). Auto suppliers covered include Magna (MGA), Goodyear Tire (GT), Adient (ADNT), Delphi Technologies (DLPH), Visteon (VC), BorgWarner (BWA), Aptiv (APTV) and Tenneco (TEN).
01/08/18
MSCO
01/08/18
NO CHANGE
MSCO
Equal Weight
Morgan Stanley says Cadillac, worth $13B to GM, can't be ignored for long
General Motors does not disclose profitability by brand, but Morgan Stanley analyst Adam Jonas believes Cadillac is probably larger and more profitable than recognized by most investors, he stated in a new note. The analyst, who values Cadillac at about $13B, or roughly $9 per GM share, believes this value cannot be ignored for long and he sees room for GM's current efforts to improve financial and strategic transparency for the brand to gain momentum. Jonas keeps an Equal Weight rating on GM shares.
M Macy's

01/05/18
BMOC
01/05/18
NO CHANGE
Target $38
BMOC
Outperform
Macy's price target raised to $38 from $35 at BMO Capital
BMO Capital analyst Wayne Hood raised his price target on Macy's to $38 and kept his Outperform rating after the company's Nov-Dec comps completed the first positive SSS Q4 since 2014. Hood notes "encouraging" improvement in brick-and-mortar comps as well as double digit growth in digital platforms, forecasting further upside from " improving consumer spending setup from tax reform and falling unemployment that could be far reaching". The analyst raises his FY17 EPS forecast to $3.63 from $3.53 and FY18 forecast to $3.18 from $2.63, reflecting a lower effective tax rate of about 25%.
12/18/17
OTRG
12/18/17
UPGRADE
OTRG
Mixed
Macy's upgraded to Mixed from Negative at OTR Global
OTR Global upgraded Macy's to Mixed following checks that indicate sell-through is meeting or exceeding plan driven by strong ecommerce trends.
01/02/18
MSCO
01/02/18
NO CHANGE
MSCO
Kohl's, Macy's Q4 same-store sales estimates raised at Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger said that overall retail traffic appeared solid following Christmas, adding that store checks and third party data points suggest better performance at Kohl's (KSS) and Macy's (M) than she originally anticipated. Greenberger raised her Q4 Kohl's comparable sales estimate to down 1% from down 3% and increased her comp sales estimate for Macy's to down 2% from down 2.5%. However, she maintains an Underweight rating on Kohl's shares and an Equal Weight rating on Macy's.
12/07/17
CLVD
12/07/17
NO CHANGE
CLVD
Macy's Q4 sales appear to be improving, says Cleveland Research

TODAY'S FREE FLY STORIES

NTR

Nutrien

$53.07

0.07 (0.13%)

05:05
01/23/18
01/23
05:05
01/23/18
05:05
Upgrade
Nutrien rating change  »

Nutrien upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 06

    Feb

NFLX

Netflix

$227.58

7.12 (3.23%)

05:01
01/23/18
01/23
05:01
01/23/18
05:01
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

ADBE

Adobe

$197.84

2.11 (1.08%)

05:00
01/23/18
01/23
05:00
01/23/18
05:00
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

ATUS

Altice USA

$21.90

0.6 (2.82%)

, ALLVF

Altice NV

$11.35

0.3675 (3.35%)

04:58
01/23/18
01/23
04:58
01/23/18
04:58
Upgrade
Altice USA, Altice NV rating change  »

Altice USA upgraded to…

ATUS

Altice USA

$21.90

0.6 (2.82%)

ALLVF

Altice NV

$11.35

0.3675 (3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

ALLVF

Altice NV

$11.35

0.3675 (3.35%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Upgrade
Altice NV rating change  »

Altice NV upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Wolfe Research utilities analyst to hold a luncheon meeting »

Senior Utilities Analyst…

RHT

Red Hat

$128.01

2.07 (1.64%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Red Hat participates in a conference call with Bernstein »

U.S. SMID-Cap Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

CAMP

CalAmp

$23.13

0.02 (0.09%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
CalAmp has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

AYR

Aircastle

$24.23

-0.03 (-0.12%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Aircastle management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

CRNCY

Cairn Energy

$6.15

0.11 (1.82%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Cairn Energy management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SRE

Sempra Energy

$105.05

-0.94 (-0.89%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Sempra Energy management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

TRN

Trinity Industries

$36.51

-0.15 (-0.41%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Trinity Industries management to meet with Wedbush »

Meeting with CFO Perry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

EPE

EP Energy

$2.48

0.17 (7.36%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
EP Energy to hold a conference call »

Management discusses its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

BNED

Barnes & Noble Education

$7.71

0.01 (0.13%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Barnes & Noble Education management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SIG

Signet Jewelers

$55.87

0.8 (1.45%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Signet Jewelers management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

UNF

UniFirst

$171.15

0.2 (0.12%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
UniFirst management to meet with Northcoast »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CQH

Cheniere Energy Partners LP

$28.50

0.28 (0.99%)

, CQP

Cheniere Energy Partners

$30.89

0.41 (1.35%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

Annual Morgan Stanley…

CQH

Cheniere Energy Partners LP

$28.50

0.28 (0.99%)

CQP

Cheniere Energy Partners

$30.89

0.41 (1.35%)

ENLC

EnLink Midstream

$19.25

0.5 (2.67%)

ENLK

EnLink Midstream Partners

$18.08

0.63 (3.61%)

EPD

Enterprise Products

$29.40

0.74 (2.58%)

NBLX

Noble Midstream

$56.22

1.12 (2.03%)

PAA

Plains All American

$23.05

0.56 (2.49%)

SHLX

Shell Midstream

$30.46

0.33 (1.10%)

TRGP

Targa Resources

$51.00

0.27 (0.53%)

WES

Western Gas Partners

$53.74

1.43 (2.73%)

WGP

Western Gas Equity

$41.91

1.49 (3.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 16

    Feb

  • 20

    Feb

  • 26

    Feb

BPL

Buckeye Partners

$55.97

0.95 (1.73%)

, CEQP

Crestwood Equity

$28.50

0.75 (2.70%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
UBS to hold a tour »

Houston Winter MLP &…

BPL

Buckeye Partners

$55.97

0.95 (1.73%)

CEQP

Crestwood Equity

$28.50

0.75 (2.70%)

ENLC

EnLink Midstream

$19.25

0.5 (2.67%)

ENLK

EnLink Midstream Partners

$18.08

0.63 (3.61%)

EPD

Enterprise Products

$29.40

0.74 (2.58%)

PAA

Plains All American

$23.05

0.56 (2.49%)

SEP

Spectra Energy Partners

$43.40

0.81 (1.90%)

SHLX

Shell Midstream

$30.46

0.33 (1.10%)

TRGP

Targa Resources

$51.00

0.27 (0.53%)

WES

Western Gas Partners

$53.74

1.43 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 09

    Feb

  • 16

    Feb

  • 20

    Feb

  • 26

    Feb

SBOW

SilverBow Resources

$31.45

-0.79 (-2.45%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
SilverBow Resources management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

FCPT

Four Corners Property Trust

$24.13

0.45 (1.90%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Four Corners Property Trust management to meet with JMP Securities »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PRQR

ProQR Therapeutics

$3.03

0.025 (0.83%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 19

    Feb

BRG

Bluerock Residential

$9.22

0.03 (0.33%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Bluerock Residential management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Abeona Therapeutics management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

STML

Stemline

$14.25

0.7 (5.17%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Stemline participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.